2seventy bio, Inc. financial data

Symbol
TSVT on Nasdaq
Location
60 Binney Street, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 405 % -10.6%
Debt-to-equity 123 % +21.9%
Return On Equity -62.3 % -21.2%
Return On Assets -28 % -9.18%
Operating Margin -490 % -269%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 51.5M shares +2.05%
Common Stock, Shares, Outstanding 51.5M shares +2.5%
Entity Public Float 508M USD +2.34%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 52.2M shares +2.39%
Weighted Average Number of Shares Outstanding, Diluted 55M shares +7.94%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 44.1M USD -70%
Research and Development Expense 162M USD -34.1%
Costs and Expenses 260M USD -24%
Operating Income (Loss) -216M USD -10.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -156M USD +13.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -156M USD +13.3%
Earnings Per Share, Basic -3.04 USD/shares +20.4%
Earnings Per Share, Diluted -3.07 USD/shares +19.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 112M USD +16.5%
Marketable Securities, Current 195M USD +45%
Assets, Current 225M USD -32.6%
Property, Plant and Equipment, Net 36.7M USD -39.8%
Operating Lease, Right-of-Use Asset 210M USD -8.78%
Intangible Assets, Net (Excluding Goodwill) 6.24M USD -10.2%
Goodwill 0 USD -100%
Assets 518M USD -26.6%
Accounts Payable, Current 3M USD -52.3%
Employee-related Liabilities, Current 6.59M USD -36.1%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 47.2M USD -29.4%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 236M USD -6.28%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 283M USD -16.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -236K USD +83.5%
Retained Earnings (Accumulated Deficit) -539M USD -40.8%
Stockholders' Equity Attributable to Parent 235M USD -36.1%
Liabilities and Equity 518M USD -26.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -41.9M USD +14.7%
Net Cash Provided by (Used in) Financing Activities 386K USD -99.7%
Net Cash Provided by (Used in) Investing Activities 21.8M USD -51.3%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 51.5M shares +2.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -19.7M USD -116%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 112M USD +15%
Deferred Tax Assets, Valuation Allowance 181M USD +41.2%
Deferred Tax Assets, Gross 249M USD +23.1%
Operating Lease, Liability 257M USD -5%
Payments to Acquire Property, Plant, and Equipment 612K USD -89.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -155M USD +13%
Lessee, Operating Lease, Liability, to be Paid 341M USD -7.54%
Property, Plant and Equipment, Gross 64M USD -43.4%
Operating Lease, Liability, Current 15.5M USD +30.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 29.5M USD +2.88%
Lessee, Operating Lease, Liability, to be Paid, Year One 28.7M USD +2.91%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 84.8M USD -14.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 32.9M USD +11.6%
Deferred Tax Assets, Operating Loss Carryforwards 38.7M USD +42%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 1.8M USD +140%
Lessee, Operating Lease, Liability, to be Paid, Year Four 35.1M USD +6.58%
Additional Paid in Capital 774M USD +2.98%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 2.11M USD -6.56%
Share-based Payment Arrangement, Expense 21.8M USD -44.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%